Trials / Not Yet Recruiting
Not Yet RecruitingNCT07433179
A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants
A Phase 1 Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SEP-479 in Healthy Adult Participants
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Septerna, Inc. · Industry
- Sex
- All
- Age
- 21 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effects of oral SEP-479 in healthy adult participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SEP-479 | Oral, capsule |
| OTHER | Placebo | Oral, capsule |
Timeline
- Start date
- 2026-03-01
- Primary completion
- 2027-02-01
- Completion
- 2027-02-01
- First posted
- 2026-02-25
- Last updated
- 2026-02-25
Source: ClinicalTrials.gov record NCT07433179. Inclusion in this directory is not an endorsement.